|1.||Arend, Rebecca C: 4 articles (10/2015 - 04/2014)|
|2.||Buchsbaum, Donald J: 4 articles (10/2015 - 04/2014)|
|3.||Li, Yonghe: 4 articles (07/2014 - 01/2011)|
|4.||Hidalgo, Bertha: 3 articles (10/2015 - 04/2014)|
|5.||Samant, Rajeev S: 3 articles (07/2014 - 04/2014)|
|6.||Li, Rui: 3 articles (03/2014 - 01/2013)|
|7.||Deng, Xingming: 3 articles (03/2014 - 01/2013)|
|8.||Sica, Gabriel L: 3 articles (03/2014 - 01/2013)|
|9.||Li, Pui-Kai: 2 articles (10/2015 - 07/2014)|
|10.||Chen, Wei: 2 articles (09/2015 - 06/2011)|
04/01/2008 - "Human infection is asymptomatic or can induce minor non specific digestive disturbances and the niclosamide is effective in one single dose. "
07/01/2004 - "Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection."
03/01/2001 - "Treatment with niclosamide, as a single oral dose, cured the infection in all subjects. "
09/01/1967 - "Efficacy of niclosamide in the treatment of Taenia taeniaeformis infections in cats."
03/01/1967 - "Chemotherapeutic trials with nemural and yomesan in experimental Taenia taeniaeformis infection of cats."
04/01/1990 - "Efficacy of niclosamide against aboriginal taeniasis in Taiwan."
09/01/2014 - "Residents with taeniasis were treated with niclosamide. "
03/20/2004 - "Treatment of taeniasis consists of niclosamide followed by a purgative. "
07/01/1990 - "Niclosamide with high activity and excellent tolerance, is a drug of choice for the treatment of taeniasis in single dose treatment while for hymenolepsiasis it needs extended course."
01/01/1985 - "[Preliminary comparison of the results of treatment of taeniasis with "Radaverm" and "Yomesan"]."
07/10/2014 - "This article reviews various aspects of niclosamide as they relate to its efficacy against cancer and associated molecular mechanisms."
09/01/2015 - "The identification of novel derivatives of Niclosamide that metabolize to Niclosamide and increase its drug exposure may provide important research tools for in vivo studies and provide drug candidates for treating cancers with dysregulated Wnt signaling including drug-resistant cancers. "
04/01/2012 - "Given its potential antitumor activity, clinical trials for niclosamide and its derivatives are warranted for cancer treatment."
10/01/2015 - "Given that niclosamide has also been used as an anthelmintic drug for decades and has been found to have activity against several types of cancer, our findings may be of relevance in understanding how both parasites and neoplastic cells respond to this compound. "
01/01/2015 - "Analysis of niclosamide's effect on 11 cancer-related signal pathway reporters reveals that three of them, the E2F1, AP1, and c-Myc-responsive reporters, are significantly inhibited. "
11/01/1991 - "The trials on a hymenolepiasis model showed that effectiveness of N-(2,5-dichlorophenyl)-2/(3-nitro-4-chlorophenyl) sulfonylamino/-5-bromobenzamide was similar to that of the well-known drug niclosamide. "
11/01/1982 - "[Effectiveness and tolerance of a 6-day course of fenasal treatment in hymenolepiasis in children]."
03/01/1977 - "[Comparative effectiveness and tolerance of different methods of treatment of hymenolepiasis with phenasal]."
01/01/1974 - "[Treatment of hymenolepiasis in adults and children with small doses of phenasal]."
09/01/1973 - "[Results with use of phenasal in treatment of patients with hymenolepiasis]."
|5.||Ovarian Neoplasms (Ovarian Cancer)
07/01/2014 - "Therefore, the objective of this study was to investigate niclosamide as a potential therapeutic agent for ovarian cancer. "
08/01/2012 - "These studies support niclosamide as a promising therapy for ovarian cancer and warrant further preclinical and clinical evaluation of this safe, clinically proven drug for the management of this devastating gynecologic malignancy."
10/01/2015 - "Niclosamide has shown activity against ovarian cancer in vitro; however, it has low bioavailability in vivo. "
10/01/2015 - "Niclosamide Analogs for Treatment of Ovarian Cancer."
07/01/2014 - "These findings warrant further research of this drug and other niclosamide analogs as a treatment option for ovarian cancer."
|8.||Lysophospholipase (Phospholipase B)
|9.||Dosage Forms (Dosage Form)
|1.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)